Onconetix, Inc. (ONCO) reporting calendar
Onconetix, Inc. files periodic reports with the SEC as ONCO on Nasdaq. Atlas tracks 18 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 10 Jul 2026 – 28 Oct 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 18
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 65 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ONCO market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001213900-26-055483 |
| 10-K | 31 Dec 2025 | 13 Mar 2026 | 72 days | 0001213900-26-027725 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001213900-25-110142 |
| 10-Q | 30 Jun 2025 | 14 Aug 2025 | 45 days | 0001213900-25-076032 |
| 10-Q | 31 Mar 2025 | 12 Jun 2025 | 73 days | 0001213900-25-053914 |
| 10-K | 31 Dec 2024 | 2 Jun 2025 | 153 days | 0001213900-25-049687 |
| 10-Q | 30 Sep 2024 | 10 Dec 2024 | 71 days | 0001213900-24-107088 |
| 10-Q | 30 Jun 2024 | 29 Aug 2024 | 60 days | 0001213900-24-073545 |
| 10-Q | 31 Mar 2024 | 20 May 2024 | 50 days | 0001213900-24-045172 |
| 10-K | 31 Dec 2023 | 11 Apr 2024 | 102 days | 0001213900-24-032225 |
| 10-Q | 30 Sep 2023 | 17 Nov 2023 | 48 days | 0001213900-23-088387 |
| 10-Q | 30 Jun 2023 | 20 Oct 2023 | 112 days | 0001013762-23-005521 |
| 10-Q | 31 Mar 2023 | 12 May 2023 | 42 days | 0001213900-23-039141 |
| 10-K | 31 Dec 2022 | 9 Mar 2023 | 68 days | 0001213900-23-018635 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0001213900-22-072376 |
| 10-Q | 30 Jun 2022 | 15 Aug 2022 | 46 days | 0001213900-22-048105 |
| 10-Q | 31 Mar 2022 | 13 May 2022 | 43 days | 0001213900-22-026516 |
| 10-K | 31 Dec 2021 | 31 Mar 2022 | 90 days | 0001213900-22-016672 |
Source: SEC EDGAR company submissions for CIK 0001782107. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.